EFMC-ISMC 2021 will cover advances in drug discovery in major therapeutic areas, including bacterial and viral infections, diseases of the brain, heart, and respiratory system, fibrotic diseases and cancer, and also feature most recent advances in new technologies.

CDD is attending the meeting and sponsoring the session "New Strategies and Agents for Targeting Gram-Negative Pathogens" chaired by Dr. Vicky Steadman, Sai Life Sciences, United Kingdom. Please join us there and also visit us in CDD's virtual booth!